| ANOVA | Effect size | Receiver operating characteristic | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Non-violent n = 79 | Violent n = 10 | F-statistic (df 1,87) | P value | Partial Eta squared |  | 95 % CI |  | 95 % CI | ||||
 | mean | S.D. | mean | S.D. |  |  |  | d | lower | upper | AUC | lower | upper |
Age | 40.9 | 12.7 | 36.1 | 9.4 | 1.342 | 0.250 | - | 0.38 | −0.27 | 1.04 | 0.62 | 0.45 | 0.80 |
Length of stay (years) | 8.0 | 9.7 | 3.0 | 5.0 | 2.243 | 0.13 | - | 0.50 | −0.16 | 1.16 | 0.73 | 0.54 | 0.91 |
Chlorpromazine equivalents | 538 | 366 | 772 | 397 | 3.6 | 0.063 | - | 0.64 | −0.03 | 1.30 | 0.67 | 0.46 | 0.88 |
Pre-morbid IQ (TOPF-UK) | 96.0 | 12.6 | 96.8 | 8.1 | 0.023 | 0.879 | - | 0.06 | −0.72 | 0.84 | .49 | 0.31 | 0.67 |
PANSS total | 62.5 | 20.0 | 90.1 | 19.4 | 12.2 | 0.001 | .157 | 1.38 | 0.58 | 2.19 | 0.84 | 0.71 | 0.97 |
PANSS positive | 13.7 | 7.0 | 21.6 | 8.7 | 9.32 | 0.003 | .113 | 1.21 | 0.41 | 2.01 | 0.79 | 0.65 | 0.93 |
PANSS negative | 18.9 | 7.9 | 25.0 | 6.5 | 6.175 | 0.111 | .078 | 0.98 | 0.19 | 1.78 | 0.71 | 0.55 | 0.87 |
PANSS general | 29.02 | 10.3 | 43.6 | 10.4 | 14.202 | .000 | .163 | 1.49 | 0.68 | 2.31 | 0.86 | 0.73 | 0.99 |
HCR-20 total score | 20.8 | 5.7 | 28.2 | 8.0 | 14.04 | 0.000 | .142 | 1.26 | 0.57 | 1.94 | 0.78 | 0.59 | 0.96 |
HCR-20 Historical | 12.9 | 2.7 | 15.2 | 4.5 | 5.178 | .025 | .057 | 0.763 | 0.09 | 1.43 | 0.75 | 0.55 | 0.95 |
HCR-20 Current | 4.50 | 2.63 | 7.2 | 2.78 | 12.59 | .001 | .129 | 1.91 | 0.51 | 1.87 | 0.76 | 0.59 | 0.94 |
HCR-20 Risk | 3.39 | 2.12 | 5.80 | 2.29 | 10.06 | .002 | .106 | 1.064 | 0.39 | 1.74 | 0.77 | 0.62 | 0.71 |
SOFAS | 59.2 | 17.2 | 35.6 | 18.9 | 14.9 | 0.001 | - | 1.29 | 0.61 | 1.98 | 0.83 | 0.66 | 0.99 |
DUNDRUM-1 (11 item) | 29.54 | 5.01 | 27.40 | 7.1 | .994 | 0.322 | .012 | 0.334 | −0.33 | 0.99 | 0.44 | 0.21 | 0.66 |
DUNDRUM-1 (9 item) | 27.08 | 3.93 | 23.90 | 6.93 | 3.275 | 0.074 | .037 | 0.607 | −0.06 | 1.27 | 0.38 | 0.16 | 0.60 |